SYDNEE HOGUE: Open Payments
NPI 1548779291 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 13 payments from 7 companies in 2025. Trend: 2023 $451 · 2024 $613 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $338 |
| Neurocrine BioSciences, Inc. | 2 | $219 |
| Alkermes, Inc. | 2 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $191 |
| ABBVIE INC. | 2 | $142 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $122 |
Products named: AUSTEDO XR, INGREZZA, CAPLYTA, VRAYLAR, LYBALVI, COBENFY, SPRAVATO, VIVITROL.
Industry payments across IL — which companies pay providers there.
